Clinical trial

Self Titration With Apidra to Reach Target Study (START)

NCT01013571

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-10-01

PhasePHASE4

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2012-03-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

insulin glargineDRUG · verified · RxNorm: insulin glargine

Apidra (insulin glulisine)DRUG

Sponsors & collaborators

Sanofilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01013571 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.